Display Settings:

Format

Send to:

Choose Destination
    J Exp Med. 1997 Aug 4;186(3):449-54.

    Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice.

    Source

    Division of Basic Sciences and Pulmonary Medicine, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, USA.

    Abstract

    Mast cells are the main effector cells of immediate hypersensitivity and anaphylaxis. Their role in the development of allergen-induced airway hyperresponsiveness (AHR) is controversial and based on indirect evidence. To address these issues, mast cell-deficient mice (W/W v) and their congenic littermates were sensitized to ovalbumin (OVA) by intraperitoneal injection and subsequently challenged with OVA via the airways. Comparison of OVA-specific immunoglobulin E (IgE) levels in the serum and numbers of eosinophils in bronchoalveolar lavage fluid or lung digests showed no differences between the two groups of mice. Further, measurements of airway resistance and dynamic compliance at baseline and after inhalation of methacholine were similar. These data indicate that mast cells or IgE-mast cell activation is not required for the development of eosinophilic inflammation and AHR in mice sensitized to allergen via the intraperitoneal route and challenged via the airways.

    PMID:
    9236197
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2198995
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 3
    Figure 1
    Figure 4
    Figure 2

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk